BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15483720)

  • 1. Iron catalysed assembly of an asymmetric mixed-ligand triple helicate.
    Bernhardt PV; Chin P; Richardson DR
    Dalton Trans; 2004 Oct; (20):3342-6. PubMed ID: 15483720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unprecedented oxidation of a biologically active aroylhydrazone chelator catalysed by iron(III): serendipitous identification of diacylhydrazine ligands with high iron chelation efficacy.
    Bernhardt PV; Chin P; Richardson DR
    J Biol Inorg Chem; 2001 Oct; 6(8):801-9. PubMed ID: 11713687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrazone chelators for the treatment of iron overload disorders: iron coordination chemistry and biological activity.
    Bernhardt PV; Chin P; Sharpe PC; Richardson DR
    Dalton Trans; 2007 Aug; (30):3232-44. PubMed ID: 17893768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexes of cytotoxic chelators from the dipyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues.
    Bernhardt PV; Mattsson J; Richardson DR
    Inorg Chem; 2006 Jan; 45(2):752-60. PubMed ID: 16411711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterocyclic dithiocarbazate iron chelators: Fe coordination chemistry and biological activity.
    Basha MT; Chartres JD; Pantarat N; Ali MA; Mirza AH; Kalinowski DS; Richardson DR; Bernhardt PV
    Dalton Trans; 2012 Jun; 41(21):6536-48. PubMed ID: 22362375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activity.
    Bernhardt PV; Chin P; Sharpe PC; Wang JY; Richardson DR
    J Biol Inorg Chem; 2005 Nov; 10(7):761-77. PubMed ID: 16193304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues.
    Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2007 Nov; 50(24):6212-25. PubMed ID: 17963372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastereopure Fe(II) and Zn(II) complexes derived from a tridentate N,N',N-bis(methyl-L-prolinate)-substituted pyridine ligand.
    Gosiewska S; Cornelissen JJ; Lutz M; Spek AL; van Koten G; Klein Gebbink RJ
    Inorg Chem; 2006 May; 45(10):4214-27. PubMed ID: 16676984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observation of redox-induced electron transfer and spin crossover for dinuclear cobalt and iron complexes with the 2,5-di-tert-butyl-3,6-dihydroxy-1,4-benzoquinonate bridging ligand.
    Min KS; Dipasquale AG; Rheingold AL; White HS; Miller JS
    J Am Chem Soc; 2009 May; 131(17):6229-36. PubMed ID: 19358538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetranuclear iron(III) complexes of an octadentate pyridine-carboxylate ligand and their catalytic activity in alkane oxidation by hydrogen peroxide.
    Gutkina EA; Trukhan VM; Pierpont CG; Mkoyan S; Strelets VV; Nordlander E; Shteinman AA
    Dalton Trans; 2006 Jan; (3):492-501. PubMed ID: 16395449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future of toxicology--iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy.
    Kalinowski DS; Richardson DR
    Chem Res Toxicol; 2007 May; 20(5):715-20. PubMed ID: 17402750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.
    Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2008 Jan; 51(2):331-44. PubMed ID: 18159922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nickel and iron complexes with N,P,N-type ligands: synthesis, structure and catalytic oligomerization of ethylene.
    Kermagoret A; Tomicki F; Braunstein P
    Dalton Trans; 2008 Jun; (22):2945-55. PubMed ID: 18493630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron(III) complexes of tridentate 3N ligands as functional models for catechol dioxygenases: the role of ligand N-alkyl substitution and solvent on reaction rate and product selectivity.
    Visvaganesan K; Mayilmurugan R; Suresh E; Palaniandavar M
    Inorg Chem; 2007 Nov; 46(24):10294-306. PubMed ID: 17958355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuning the antiproliferative activity of biologically active iron chelators: characterization of the coordination chemistry and biological efficacy of 2-acetylpyridine and 2-benzoylpyridine hydrazone ligands.
    Bernhardt PV; Wilson GJ; Sharpe PC; Kalinowski DS; Richardson DR
    J Biol Inorg Chem; 2008 Jan; 13(1):107-19. PubMed ID: 17899222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination versatility of tridentate pyridyl aroylhydrazones towards iron: tracking down the elusive aroylhydrazono-based ferric spin-crossover molecular materials.
    Shongwe MS; Al-Rahbi SH; Al-Azani MA; Al-Muharbi AA; Al-Mjeni F; Matoga D; Gismelseed A; Al-Omari IA; Yousif A; Adams H; Morris MJ; Mikuriya M
    Dalton Trans; 2012 Feb; 41(8):2500-14. PubMed ID: 22216420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A turn-on fluorescent iron complex and its cellular uptake.
    Chartres JD; Busby M; Riley MJ; Davis JJ; Bernhardt PV
    Inorg Chem; 2011 Sep; 50(18):9178-83. PubMed ID: 21812394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic structure of mononuclear bis(1,2-diaryl-1,2-ethylenedithiolato)iron complexes containing a fifth cyanide or phosphite ligand: a combined experimental and computational study.
    Patra AK; Bill E; Bothe E; Chlopek K; Neese F; Weyhermüller T; Stobie K; Ward MD; McCleverty JA; Wieghardt K
    Inorg Chem; 2006 Sep; 45(19):7877-90. PubMed ID: 16961381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel iron(III) complexes of sterically hindered 4N ligands: regioselectivity in biomimetic extradiol cleavage of catechols.
    Mayilmurugan R; Stoeckli-Evans H; Palaniandavar M
    Inorg Chem; 2008 Aug; 47(15):6645-58. PubMed ID: 18597419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents.
    Becker EM; Lovejoy DB; Greer JM; Watts R; Richardson DR
    Br J Pharmacol; 2003 Mar; 138(5):819-30. PubMed ID: 12642383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.